NutriBand Inc. (NTRB) shareholders
Close on Nov 13, 2026Market cap $74.15MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Nociata Holding Limited Joint filing with Vitale Botgros (32.37%), T.I.I. - Jetservices, Lda (16.06%) | 4,179,842 | 32.00% | 13D (active) amendment | Apr 19, 2024 |
| Gareth Sheridan | 1,786,000 | 14.20% | 13D (active) amendment | Sep 29, 2021 |
| Serguei Melnik | 1,071,418 | 9.39% | 13D (active) | Sep 29, 2021 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NTRB | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 174,927 | 1.44% | $558.02K | – | 0.00% |
| Geode Capital Management, LLC | 62,494 | 0.51% | $199.40K | −7,559 | 0.00% |
| Vanguard Fiduciary Trust Co | 25,111 | 0.21% | $80.10K | – | 0.00% |
| State Street Corp | 24,966 | 0.21% | $79.64K | – | 0.00% |
| Citadel Advisors LLC | 18,996 | 0.16% | $60.60K | New | 0.00% |
| Northern Trust Corp | 11,570 | 0.10% | $36.91K | −2,375 | 0.00% |
| Haven Private, LLC | 11,366 | 0.09% | $36.26K | – | 0.01% |
| BlackRock, Inc. | 10,662 | 0.09% | $34.01K | +1,121 | 0.00% |
| Osaic Holdings, Inc. | 3,684 | 0.03% | $11.75K | −1,167 | 0.00% |
| Vanguard Global Advisers, LLC | 2,700 | 0.02% | $8.61K | – | 0.00% |
| Wells Fargo & Company/Mn | 2,600 | 0.02% | $8.29K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 2,107 | 0.02% | $6.72K | +1,077 | 0.00% |
| UBS Group AG | 672 | 0.01% | $2.14K | −31,992 | 0.00% |
| Jones Financial Companies Lllp | 466 | 0.00% | $1.43K | – | 0.00% |
| Barclays PLC | 19 | 0.00% | $61 | New | 0.00% |
| Harbour Investments, Inc. | 3 | 0.00% | $10 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 16 | 0M | 2.9% | 2 / 2 | 4 / 0 | 0M | 0M |
| Q1 2026 | 14 | 0M | 3.1% | 3 / 3 | 3 / 7 | 0M | 0M |
| Q4 2025 | 19 | 0M | 3.0% | 3 / 1 | 6 / 3 | 0M | 0M |
| Q3 2025 | 19 | 0M | 3.1% | 4 / 5 | 4 / 3 | 0M | 0M |
| Q2 2025 | 20 | 0M | 2.9% | 7 / 5 | 3 / 3 | 0M | 0M |
| Q1 2025 | 16 | 0M | 2.8% | 5 / 4 | 4 / 2 | 0M | 0M |
| Q4 2024 | 13 | 0M | 2.0% | 2 / 3 | 4 / 4 | 0M | 0M |
| Q3 2024 | 15 | 0M | 2.3% | 2 / 4 | 2 / 4 | 0M | 0M |
| Q2 2024 | 18 | 0M | 2.2% | 6 / 7 | 1 / 2 | 0M | 0M |
| Q1 2024 | 14 | 0M | 2.1% | 3 / 5 | 3 / 1 | 0M | 0M |
| Q4 2023 | 12 | 0M | 1.6% | 1 / 4 | 3 / 0 | 0M | 0M |
| Q3 2023 | 11 | 0M | 1.7% | 1 / 1 | 4 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
9 funds held NTRB in Q2 2026, 76% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of NTRB | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 122,586 | 1.01% | $391.05K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 52,341 | 0.43% | $166.97K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 32,875 | 0.27% | $114.73K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 9,994 | 0.08% | $31.88K | 0.00% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 9,774 | 0.08% | $34.11K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 8,237 | 0.07% | $28.75K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 7,231 | 0.06% | $25.24K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 668 | 0.01% | $2.13K | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -300 | -0.00% | -$957 | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Gareth Sheridan | Chief Executive Officer, Director, 10% owner | 1,761,667 | 14.49% | Nov 25, 2025 |
| Serguei Melnik | President and Secretary, Director | 1,127,999 | 9.28% | Nov 29, 2024 |
| Gerald Goodman | Chief Financial Officer | 66,085 | 0.54% | Oct 21, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Gerald Goodman Chief Financial Officer | Oct 27, 2023 | Option exercise | +60,085 | $1.93 | $115.96K | 66,085 |
| Serguei Melnik Chairman and President, Director, 10% owner | Mar 6, 2023 | Gift | −5,000 | – | – | 827,999 |
| Gareth Sheridan CEO, Director, 10% owner | Jun 15, 2022 | Gift | −10,000 | – | – | 1,510,000 |
| Gareth Sheridan CEO, Director, 10% owner | May 10, 2022 | Award | +10,000 | $3.80 | $38.00K | 1,520,000 |
| Serguei Melnik Chairman and President, Director | Feb 24, 2022 | Buy | +500 | $4.03 | $2.02K | 633,000 |
| Serguei Melnik Chairman and President, Director | Feb 24, 2022 | Buy | −5,000 | $4.03 | $20.15K | 637,500 |
| Serguei Melnik Chairman and President, Director | Feb 24, 2022 | Buy | −500 | $4.03 | $2.02K | 633,000 |
| Serguei Melnik Chairman and President, Director | Feb 6, 2022 | Gift | −10,000 | – | – | 632,500 |
| Gareth Sheridan CEO, Director, 10% owner | Jan 5, 2021 | Award | +10,000 | $15.00 | $150.00K | 1,510,000 |
| Serguei Melnik CFO, Director | May 30, 2019 | Gift | −20,000 | – | – | 2,530,000 |
| Gerald Goodman Chief Financial Officer | Jan 10, 2019 | Award | +26,250 | – | – | 26,250 |
| Michael Davidov Director | Jul 31, 2018 | Award | +5,000 | – | – | 5,000 |
| Serguei Melnik CFO, Director, 10% owner | Aug 19, 2017 | Gift | −450,000 | – | – | 2,550,000 |
| Gareth Sheridan CEO, Director, 10% owner | Aug 17, 2017 | Gift | −1,000,000 | – | – | 6,000,000 |
| Gareth Sheridan CEO, Director | Aug 9, 2017 | Gift | −1,000,000 | – | – | 6,000,000 |
| Gareth Sheridan CEO, Director, 10% owner | Nov 30, 2016 | Other | −7,000,000 | – | – | 7,000,000 |
| Vitalie Botgros Chairman of the BOD, Director, 10% owner | Jan 15, 2016 | Discretionary | +3,000,000 | – | – | 3,000,000 |
| Serguei Melnik Chief Financial Officer, Director, 10% owner | Jan 15, 2016 | Discretionary | +3,000,000 | – | – | 3,000,000 |
| Gareth Sheridan CEO, Director, 10% owner | Jan 15, 2016 | Other | +2,500,000 | – | – | 7,000,000 |
| Gareth Sheridan CEO, Director, 10% owner | Jan 15, 2016 | Discretionary | +11,500,000 | – | – | 7,000,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of NutriBand's stock actually held short. Settlement fails (shares not delivered on time) peaked at 13,329 shares on Sep 23, 2026 over the last 90 days.
See a number that looks wrong?